Veeva Systems (NYSE:VEEV) is a leading provider of cloud-based software solutions designed specifically for the global life sciences industry. Founded in 2007 and headquartered in Pleasanton, California, the company delivers applications that streamline critical processes across research, development, quality, regulatory, and commercial functions. By leveraging a modern, multitenant cloud architecture, Veeva aims to help biotechnology, pharmaceutical, and medical device companies accelerate time to market, maintain compliance, and improve overall operational efficiency.
The company’s flagship offering, the Veeva Vault platform, provides a unified content management and data repository for regulated documents and workflows. Vault supports a wide range of use cases such as clinical trial documentation, regulatory submissions, quality management, and safety reporting. In addition to Vault, Veeva’s commercial suite—which includes Veeva CRM and Veeva Commercial Cloud—enables life sciences organizations to manage customer relationships, deploy multichannel marketing campaigns, and gain actionable insights through integrated analytics.
Over time, Veeva has expanded its portfolio to address emerging industry needs in areas like real-world evidence collection, regulatory information management, and pharmacovigilance. The company serves customers of all sizes—from large multinational pharmaceutical firms to specialty and emerging biotech companies—across North America, Europe, Asia Pacific, Latin America, and other markets worldwide. Veeva’s solutions are tailored to meet regional regulatory requirements while supporting global collaboration and data integrity.
Peter Gassner, co-founder and chief executive officer, has led Veeva since its inception and guided its growth from a startup to a publicly traded company following its initial public offering in 2013. Under his leadership, Veeva continues to invest in research and development to expand its application suite and enhance platform capabilities. The company’s executive team combines deep expertise in life sciences and enterprise software, positioning Veeva to address the evolving challenges of highly regulated industries.